The purpose of this study is to evaluate the efficacy and safety of ONO-5334 in postmenopausal women with osteopenia or osteoporosis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
285
Andromed Noord Groningen
Damsterdiep 9, Provincie Groningen, Netherlands
Mean bone mineral density of the lumbar spine (L 1-4 BMD)
Time frame: 12 months
Bone mineral density at hip, Biochemical markers of bone turnover
Time frame: during course of treatment of 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
300mg QD /24 mos.
Alendronate 70mg once weekly / 24 mos